MedTrace Logo

Resonance Breathing and Postural Resonance: Acute Modulation of Autonomic and Hemodynamic Responses Via Arterial Baroreflex Mechanisms

NCT07536997 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-04-17

No results posted yet for this study

Summary

This study aimed to compare the acute autonomic and hemodynamic effects of two arterial baroreflex resonance interventions-Resonance Breathing (RB) and Postural Resonance (PR)-in healthy young adults. Methods: A randomized crossover design was conducted in 27 healthy participants (aged 18-25). Each participant completed three experimental sessions (control, RB, and PR) separated by a 5-day washout period. Each session included a 15-minute baseline, a 15-minute intervention, and a 5-min recovery phase. Continuous recordings of skin sympathetic nerve activity (SKNA) and heart rate variability (HRV) were collected throughout each session, while blood pressure (BP) and pulse wave velocity (PWV) were measured before and after the interventions.

Conditions

  • Autonomic Nervous System Disease

Interventions

BEHAVIORAL

Postural Resonance

A structured intervention focusing on postural resonance alignment. The protocol aims to acutely modulate autonomic nervous system activity and hemodynamic responses via stimulation of the arterial baroreflex. Sessions include guided breathing practice, postural adjustment, and feedback on breathing mechanics

BEHAVIORAL

Resonance Breathing

A structured intervention focusing on resonance breathing ( slow, rhythmic breathing at spontaneous resonance frequency ) . The protocol aims to acutely modulate autonomic nervous system activity and hemodynamic responses via stimulation of the arterial baroreflex.

Sponsors & Collaborators

  • Beijing Sport University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2024-06-15
Completion
2026-04-10

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07536997 on ClinicalTrials.gov